BerandaPHS • FRA
add
Photocure ASA
Tutup sebelumnya
€5,73
Rentang hari
€5,87 - €5,87
Rentang tahun
€3,97 - €5,87
Volume Rata-Rata
16,00
Rasio P/E
-
Hasil dividen
-
Berita pasar
Kaltimtoday.co
20 jam yang lalu
Wall Street Tutup 2025 di Zona Merah, S&P 500 Naik 16,4% dalam Setahun
0,74%
Keuangan
Laporan Laba Rugi
Pendapatan
Penghasilan bersih
| (NOK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 134,96Â jt | 12,26% |
Biaya operasional | 120,69Â jt | 5,35% |
Penghasilan bersih | 3,98Â jt | 214,92% |
Margin laba bersih | 2,95 | 202,43% |
Penghasilan per saham | 0,15 | 215,38% |
EBITDA | 9,72Â jt | 93,42% |
Tarif pajak efektif | 1.100,75% | — |
Neraca
Total aset
Total liabilitas
| (NOK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 247,77Â jt | -14,87% |
Total aset | 696,70Â jt | -3,30% |
Total liabilitas | 210,10Â jt | -4,82% |
Total ekuitas | 486,60 jt | — |
Saham yang beredar | 26,61 jt | — |
Harga terhadap nilai buku | 0,31 | — |
Tingkat pengembalian aset | 0,86% | — |
Tingkat pengembalian modal | 1,20% | — |
Arus Kas
Perubahan kas bersih
| (NOK) | Sep 2025info | Perubahan Y/Y |
|---|---|---|
Penghasilan bersih | 3,98Â jt | 214,92% |
Kas dari operasi | 29,21Â jt | -15,41% |
Kas dari investasi | -8,48Â jt | -449,51% |
Kas dari pembiayaan | -12,07Â jt | 6,40% |
Perubahan kas bersih | 8,66Â jt | -64,02% |
Arus kas bebas | 13,42Â jt | -46,63% |
Tentang
Photocure ASA is a Norwegian specialty pharma company that develops and sells pharmaceuticals and medical devices based on proprietary photodynamic technology. Photocure's strategy in cancer is to continue the commercialization of Hexvix for bladder cancer diagnostics, and continue the development of the cancer portfolio and out-license prior to phase III studies. This strategy is based on a strong platform of intellectual property in photodynamic therapy. Wikipedia
Didirikan
1993
Situs
Karyawan
100
